Pharmacotherapy of Insomnia

Article information

J Korean Med Assoc. 2009;52(7):719-726
Publication date (electronic) : 2009 July 31
doi : https://doi.org/10.5124/jkma.2009.52.7.719
Department of Psychiatry, Gachon University College of Medicine, Korea. sjkim@gilhospital.com

Abstract

As insomnia is a common symptom caused by diverse disorders, treatment tools for the insomnia differ depending on the underlying cause. Hypnotics can be used for primary insomnia. As hypnotics show excellent short-term efficacy, they would be useful as short-term (< 4 weeks) treatments for transient insomnia. There has been much controversy over long-term hypnotic use for chronic insomnia. Evidence supporting safety and efficacy of the long-term hypnotic use is insufficient. Therefore, rather than using hypnotics alone, non-pharmacological treatments are recommended more for chronic primary insomnia. Although various benzodiazepines have widely been used as hypnotics, there have been concerns over tolerance, rebound insomnia, dependency, cognitive decline and psychomotor slowness. In efforts to relieve these concerns, selective benzodiazepine agonists like zolpidem have been introduced as novel hypnotics. Sedating antidepressants, melatonin and anti-histamine have also been used in order to manage insomnia. However, their efficacy for primary insomnia has yet to be proven.

References

1. Kryger MH, Roth T, Dement WC, eds. Principle and practice of sleep medicine 2005. Philadelphia: Elsevier; 444–467. 726–760.
2. Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 2006. 4168–192.
3. Wilson S, Nutt D. Drug treatment of chronic insomnia - dawn at the end of a long night? J Psychopharmacol 2008. 22703–706.
4. Riemann D, Perlis ML. The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 2009. 13205–214.
5. Dubovsky S. In : Sadock BJ, Sadock VA, eds. Benzodiazepine receptor agonists and antagonists. Comprehensive textbook of psychiatry 2005. Philadelphia: Lippincott Williams & Wilkins; 2781–2791.

Article information Continued

Table 1

Characteristics of benzodiazepine receptor agonist used for insomnia.

Table 1